These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15760710)

  • 1. Membrane viscosity is a major modulating factor of the enterocin CRL35 activity.
    Minahk CJ; Saavedra L; Sesma F; Morero R
    Biochimie; 2005 Feb; 87(2):181-6. PubMed ID: 15760710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of the class IIa bacteriocin receptor function and membrane structural changes are associated to enterocin CRL35 high resistance in Listeria monocytogenes.
    Masias E; Dupuy FG; da Silva Sanches PR; Farizano JV; Cilli E; Bellomio A; Saavedra L; Minahk C
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1770-1776. PubMed ID: 28323072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short peptides derived from the NH2-terminus of subclass IIa bacteriocin enterocin CRL35 show antimicrobial activity.
    Salvucci E; Saavedra L; Sesma F
    J Antimicrob Chemother; 2007 Jun; 59(6):1102-8. PubMed ID: 17449885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35.
    Minahk CJ; Dupuy F; Morero RD
    J Antimicrob Chemother; 2004 Feb; 53(2):240-6. PubMed ID: 14729738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into enterocin CRL35: mechanism of action and immunity revealed by heterologous expression in Escherichia coli.
    Barraza DE; Ríos Colombo NS; Galván AE; Acuña L; Minahk CJ; Bellomio A; Chalón MC
    Mol Microbiol; 2017 Sep; 105(6):922-933. PubMed ID: 28692133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriocin enterocin CRL35 is a modular peptide that induces non-bilayer states in bacterial model membranes.
    Medina Amado C; Minahk CJ; Cilli E; Oliveira RG; Dupuy FG
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183135. PubMed ID: 31738901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of synthetic enterocin CRL35 with cell wall, membrane-acting antibiotics and muranolytic enzymes against Listeria cells.
    Salvucci E; Hebert EM; Sesma F; Saavedra L
    Lett Appl Microbiol; 2010 Aug; 51(2):191-5. PubMed ID: 20672439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterocin CRL35 inhibits Listeria monocytogenes in a murine model.
    Salvucci E; Saavedra L; Hebert EM; Haro C; Sesma F
    Foodborne Pathog Dis; 2012 Jan; 9(1):68-74. PubMed ID: 22011041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of enterocin CRL35 on Listeria monocytogenes cell membrane.
    Minahk CJ; Farías ME; Sesma F; Morero RD
    FEMS Microbiol Lett; 2000 Nov; 192(1):79-83. PubMed ID: 11040432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 28-mer Fragment Derived from Enterocin CRL35 Displays an Unexpected Bactericidal Effect on Listeria Cells.
    Masias E; Sanches PR; Dupuy FG; Acuna L; Bellomio A; Cilli E; Saavedra L; Minahk C
    Protein Pept Lett; 2015; 22(6):482-8. PubMed ID: 25962066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence anisotropy analysis of the mechanism of action of mesenterocin 52A: speculations on antimicrobial mechanism.
    Jasniewski J; Cailliez-Grimal C; Younsi M; Millière JB; Revol-Junelles AM
    Appl Microbiol Biotechnol; 2008 Nov; 81(2):339-47. PubMed ID: 18784922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two-peptide class II bacteriocins: structure, production, and mode of action.
    Oppegård C; Rogne P; Emanuelsen L; Kristiansen PE; Fimland G; Nissen-Meyer J
    J Mol Microbiol Biotechnol; 2007; 13(4):210-9. PubMed ID: 17827971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the enterocin CRL35 activity by a synthetic peptide derived from the NH2-terminal sequence.
    Saavedra L; Minahk C; de Ruiz Holgado AP; Sesma F
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2778-81. PubMed ID: 15215149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of enterocin CRL35 antibiotic activity by mono- and divalent ions.
    Minahk CJ; Morero RD
    Lett Appl Microbiol; 2003; 37(5):374-9. PubMed ID: 14633107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of replacing glutamic residues upon the biological activity and stability of the circular enterocin AS-48.
    Sánchez-Hidalgo M; Martínez-Bueno M; Fernández-Escamilla AM; Valdivia E; Serrano L; Maqueda M
    J Antimicrob Chemother; 2008 Jun; 61(6):1256-65. PubMed ID: 18385141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of lipid bilayer effective microviscosity and fluidity effect induced by propofol.
    Bahri MA; Heyne BJ; Hans P; Seret AE; Mouithys-Mickalad AA; Hoebeke MD
    Biophys Chem; 2005 Apr; 114(1):53-61. PubMed ID: 15792861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for class II bacteriocins: A biophysical approach using "suicide probes" in receptor-free hosts to study their mechanism of action.
    Ríos Colombo NS; Chalón MC; Dupuy FG; Gonzalez CF; Bellomio A
    Biochimie; 2019 Oct; 165():183-195. PubMed ID: 31381962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnological use of dairy by-products for the production and microencapsulation of the food preservative enterocin CRL35.
    Farizano JV; Díaz Vergara LI; Masias E; Baillo AA; Torino MI; Fadda S; Vanden Braber NL; Montenegro MA; Saavedra L; Minahk C
    FEMS Microbiol Lett; 2022 Apr; 369(1):. PubMed ID: 35325116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A.
    Thennarasu S; Lee DK; Poon A; Kawulka KE; Vederas JC; Ramamoorthy A
    Chem Phys Lipids; 2005 Oct; 137(1-2):38-51. PubMed ID: 16095584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces.
    Clayton JC; Hughes E; Middleton DA
    Biochemistry; 2005 Dec; 44(51):17016-26. PubMed ID: 16363815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.